Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Grossman

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Journal of Neuroendocrinology|March 23, 2021
Misleading <sup>68</sup> GALLIUM-dotatate PET scan in a patient with a history of a phaeochromocytoma: Unsuspected uptake in papillary thyroid carcinoma metastasesDaniel Moffat, Polly Richards, Tom R Kurzawinski, et al.
Endocrine-Related Cancer|April 13, 2017
Molecular targeted therapies in adrenal, pituitary and parathyroid malignanciesAnna Angelousi, Georgios K Dimitriadis, Georgios Zografos, et al.
Endocrine-Related Cancer|July 28, 2016
Medical management of secretory syndromes related to gastroenteropancreatic neuroendocrine tumoursGeorgios K Dimitriadis, Martin O Weickert, Harpal S Randeva, et al.
European Journal of Endocrinology|December 22, 2017
Transsphenoidal surgery for pituitary tumours: frequency and predictors of delayed hyponatraemia and their relationship to early readmissionJesper Krogh, Caroline N Kistorp, Bahram Jafar-Mohammadi, et al.
Journal of Neuroendocrinology|March 26, 2021
Diabetes insipidus secondary to sellar/parasellar lesionsAnna Angelousi, Chrysoula Mytareli, Paraskevi Xekouki, et al.
Cancers|October 11, 2019
Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision MedicineSvenja Nölting, Martin Ullrich, Jens Pietzsch, et al.
Endocrine-Related Cancer|October 24, 2019
Neoplastic metastases to the endocrine glandsAnna Angelousi, Krystallenia I Alexandraki, George Kyriakopoulos, et al.
Chest|November 29, 2012
Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 studyNicola Fazio, Dan Granberg, Ashley Grossman, et al.
Endocrine-Related Cancer|March 26, 2017
Paraneoplastic endocrine syndromesGeorgios K Dimitriadis, Anna Angelousi, Martin O Weickert, et al.
Clinical Endocrinology|September 11, 2019
What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?Benjamin G Challis, Ruth T Casey, Ashley Grossman, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Journal of Neuroendocrinology|March 23, 2021
Misleading <sup>68</sup> GALLIUM-dotatate PET scan in a patient with a history of a phaeochromocytoma: Unsuspected uptake in papillary thyroid carcinoma metastasesDaniel Moffat, Polly Richards, Tom R Kurzawinski, et al.
Endocrine-Related Cancer|April 13, 2017
Molecular targeted therapies in adrenal, pituitary and parathyroid malignanciesAnna Angelousi, Georgios K Dimitriadis, Georgios Zografos, et al.
Endocrine-Related Cancer|July 28, 2016
Medical management of secretory syndromes related to gastroenteropancreatic neuroendocrine tumoursGeorgios K Dimitriadis, Martin O Weickert, Harpal S Randeva, et al.
European Journal of Endocrinology|December 22, 2017
Transsphenoidal surgery for pituitary tumours: frequency and predictors of delayed hyponatraemia and their relationship to early readmissionJesper Krogh, Caroline N Kistorp, Bahram Jafar-Mohammadi, et al.
Journal of Neuroendocrinology|March 26, 2021
Diabetes insipidus secondary to sellar/parasellar lesionsAnna Angelousi, Chrysoula Mytareli, Paraskevi Xekouki, et al.
Cancers|October 11, 2019
Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision MedicineSvenja Nölting, Martin Ullrich, Jens Pietzsch, et al.
Endocrine-Related Cancer|October 24, 2019
Neoplastic metastases to the endocrine glandsAnna Angelousi, Krystallenia I Alexandraki, George Kyriakopoulos, et al.
Chest|November 29, 2012
Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 studyNicola Fazio, Dan Granberg, Ashley Grossman, et al.
Endocrine-Related Cancer|March 26, 2017
Paraneoplastic endocrine syndromesGeorgios K Dimitriadis, Anna Angelousi, Martin O Weickert, et al.
Clinical Endocrinology|September 11, 2019
What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?Benjamin G Challis, Ruth T Casey, Ashley Grossman, et al.
Pageof 11